This content requires Adobe Flash Player version
Either you do not have Adobe Flash Player installed,
or your version is too old,
or there is a problem with your Flash installation and we were unable to detect it.
Doses to achieve peak plasma concentrations of 50–100mcg/ml.
High-dose ibuprofen may slow the progression of lung disease in people with CF. However it is not widely used due to its modest advantages and side effect profile e.g. GI complications and renal disease
Variable dose according to indication
Used for the management of asthma, ABPA, small airways disease and as anti-inflammatory. Has been used in combination with iv antibiotics in Cepacia syndrome.
Monitor glucose levels. Consider appropriate bone prophylaxis. Inform patient of long- term side effects
Montelukast® (leukotriene receptor
antagonists) Oral 10MG OD
Treatment of asthma, allergic rhinitis, and exercise induced bronchospasm. May have anti-inflammatory activity in patients with CF.